These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31624974)

  • 1. Lipidomic insights to understand membrane dynamics in response to vanillin in Mycobacterium smegmatis.
    Sharma S; Hameed S; Fatima Z
    Int Microbiol; 2020 May; 23(2):263-276. PubMed ID: 31624974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic Insight of Anticandidal Perillyl Alcohol and Sesamol Induced Candida Membrane Disruption: Implications of Lipid Alteration, Impaired Fluidity and Flippase Activity.
    Fatima Z; Hameed S
    Infect Disord Drug Targets; 2020; 20(6):784-797. PubMed ID: 31657691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial mechanism of vanillin involves disruption of cell-surface integrity, virulence attributes, and iron homeostasis.
    Sharma S; Pal R; Hameed S; Fatima Z
    Int J Mycobacteriol; 2016 Dec; 5(4):460-468. PubMed ID: 27931688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rec A disruption unveils cross talk between DNA repair and membrane damage, efflux pump activity, biofilm formation in Mycobacterium smegmatis.
    Hans S; Purkait D; Nandan S; Bansal M; Hameed S; Fatima Z
    Microb Pathog; 2020 Dec; 149():104262. PubMed ID: 32439563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative label-free lipidomic analysis of Mycobacterium tuberculosis during dormancy and reactivation.
    Raghunandanan S; Jose L; Gopinath V; Kumar RA
    Sci Rep; 2019 Mar; 9(1):3660. PubMed ID: 30842473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide.
    Tyagi P; Dharmaraja AT; Bhaskar A; Chakrapani H; Singh A
    Free Radic Biol Med; 2015 Jul; 84():344-354. PubMed ID: 25819161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
    Bailo R; Bhatt A; Aínsa JA
    Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative lipidomics of drug sensitive and resistant
    Pal R; Hameed S; Kumar P; Singh S; Fatima Z
    3 Biotech; 2017 Oct; 7(5):325. PubMed ID: 28955622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoterpenoid Geraniol Improves Anti-mycobacterial Drug Efficiency by Interfering with Lipidome and Virulence of Mycobacteria.
    Sharma S; Hameed S; Fatima Z
    Infect Disord Drug Targets; 2020; 20(4):467-485. PubMed ID: 31241021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
    Howard NC; Marin ND; Ahmed M; Rosa BA; Martin J; Bambouskova M; Sergushichev A; Loginicheva E; Kurepina N; Rangel-Moreno J; Chen L; Kreiswirth BN; Klein RS; Balada-Llasat JM; Torrelles JB; Amarasinghe GK; Mitreva M; Artyomov MN; Hsu FF; Mathema B; Khader SA
    Nat Microbiol; 2018 Oct; 3(10):1099-1108. PubMed ID: 30224802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidomics revealed the global lipid responses of primary bovine alveolar macrophages to infections of Mycobacterium tuberculosis and Mycobacterium bovis.
    Gao W; Cai Y; Zhang G; Wang X; Wang J; Li Y; Wang Y
    Int Immunopharmacol; 2022 Mar; 104():108407. PubMed ID: 34924313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights into the Anticandidal Action of Vanillin Reveal Disruption of Cell Surface Integrity and Mitochondrial Functioning.
    Saibabu V; Fatima Z; Khan LA; Hameed S
    Infect Disord Drug Targets; 2021; 21(3):405-415. PubMed ID: 32614756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activities of novel fluoroquinolones.
    Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
    Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
    Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MmbR, a master transcription regulator that controls fatty acid β-oxidation genes in Mycolicibacterium smegmatis.
    Xu H; Su Z; Li W; Deng Y; He ZG
    Environ Microbiol; 2021 Feb; 23(2):1096-1114. PubMed ID: 32985741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
    Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
    J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
    Saxena S; Samala G; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 Apr; 23(7):1402-12. PubMed ID: 25766629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell wall enrichment unveils proteomic changes in the cell wall during treatment of Mycobacterium smegmatis with sub-lethal concentrations of rifampicin.
    Hermann C; Giddey AD; Nel AJM; Soares NC; Blackburn JM
    J Proteomics; 2019 Jan; 191():166-179. PubMed ID: 29466714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.